Additionally, the promoting effect of HIF‐2α on NASH may be mediated by the NF‐κB signaling pathway, which facilitates the progression of NASH to liver fibrosis and increases the expression of inflammation‐related genes. The gene discussed is EPAS1; the disease is metabolic dysfunction-associated steatohepatitis.